Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01208974 · ClinicalTrials.gov registry record · NA

Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction

A NA study of Breast Cancer and Ductal Carcinoma, sponsored by University of Miami.

Active
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT01208974 is a NA study of Breast Cancer and Ductal Carcinoma that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 21 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01208974, a NA study of Breast Cancer and Ductal Carcinoma, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to see if a participant's nipple and areola can be safely preserved by adding radiation to these areas after a nipple-sparing mastectomy and immediate breast reconstruction.

Interventions

  • PROCEDURE Nipple-Sparing Mastectomy
  • PROCEDURE Breast Reconstruction
  • PROCEDURE Axillary Surgery
  • RADIATION Prophylactic Nipple-Areolar Complex RT

Study Locations (1)

Florida

  • University of Miami Sylvester Comprehensive Cancer Center - Miami

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2010-03-16
Est. Completion 2026-05-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT01208974

The ClinicalTrials.gov registry entry for NCT01208974 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Nipple-Sparing Mastectomy is the first listed.

NCT01208974 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01208974 about?

NCT01208974 is a clinical study titled "Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction". The purpose of this research study is to see if a participant's nipple and areola can be safely preserved by adding radiation to these areas after a nipple-sparing mastectomy and immediate breast reconstruction.

What is the current status of trial NCT01208974?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2010-03-16. Estimated completion is 2026-05-31.

What conditions does trial NCT01208974 study?

This clinical trial studies the following conditions: Breast Cancer, Ductal Carcinoma.

What interventions are being tested in trial NCT01208974?

The interventions under investigation include: Nipple-Sparing Mastectomy (PROCEDURE), Breast Reconstruction (PROCEDURE), Axillary Surgery (PROCEDURE), Prophylactic Nipple-Areolar Complex RT (RADIATION).

Who is sponsoring clinical trial NCT01208974?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01208974 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.